Pharma Industry News

Nabriva hit with FDA rejection of Contempo for complicated urinary tract infections

The company cited issues related to facility inspections and manufacturing deficiencies at one contract manufacturer.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]